Effects of GnRH Analogues on Prostate Cancer
Author Information
Author(s): A. Qayuml, W. Gullick, R.C. Clayton, K. Sikora, J. Waxman
Primary Institution: Royal Postgraduate Medical School, Northwick Park Hospital, London, UK
Hypothesis
The study investigates the direct regulatory effect of gonadotrophin releasing hormone (GnRH) analogues on prostatic cancer cell growth.
Conclusion
GnRH analogues can stimulate the growth of androgen-sensitive prostatic cancer cells and may play a role in prostatic epithelial cell growth in vivo.
Supporting Evidence
- High affinity binding of a GnRH analogue was observed in the human androgen-sensitive prostatic cancer cell line LNCaP.
- Nineteen of 22 malignant tumors exhibited high affinity GnRH-analogue binding.
- Seventy-six human benign and malignant tumors were assayed following surgical resection.
Takeaway
This study found that a hormone called GnRH can help prostate cancer cells grow, which is surprising because we usually think hormones slow down cancer.
Methodology
The study involved binding assays and biological response studies using human prostatic cancer cell lines and biopsy samples.
Limitations
The study does not clarify whether GnRH itself has mitogenic activity or its synergy with other growth factors.
Participant Demographics
The study included 76 human benign and malignant prostate tumors.
Want to read the original?
Access the complete publication on the publisher's website